Tokyo, 101-8535 Japan
DIN: 02010909 Status: Marketed Status date: 2022-07-19 Filter items Showing 1 to 1 of 1 entries Show
DESCRIPTION PROSCAR* (finasteride), a synthetic 4-azasteroid compound, is a specific inhibitor of steroid Type II 5α-reductase, an intracellular enzyme that converts the
In Canada, suicidal ideation is not listed in the Canadian product monographs (CPMs) for Proscar and Propecia, Footnote 1 as evidence is limited at this time and insufficient to
Date of Revision: 16766 route
The Product Monograph is a scientific document that describes the properties, claims, indications and conditions of use of the product and contains any
In clinical trials, oral finasteride therapy BPH is a condition in men in which the prostate gland is enlarged
While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate
1 Decreased Placebo 3
The onset of events ranged from 4 days to several years
3, 8
ROGAINE MINOXIDIL TOPICAL 2% SOLUTION and Men’s ROGAINE FOAM 5% are only effective for the treatment of male vertex alopecia androgenetica
Film-coated Tablets 5 mg
PROZAC Product Monograph Page 4 of 49 Geriatrics (≥ 60 years of age): Evidence from clinical studies and experience suggests that use in the geriatric population may be associated with differences in safety or effectiveness, and a brief discussion can be found in the appropriate sections (WARNINGS AND PRECAUTIONS, PRODUCT MONOGRAPH Pr APO-FINASTERIDE 5 mg finasteride Film-coated Tablets 5 mg Type II 5α-reductase inhibitor Apotex Inc
190925 Date of approval: December 15, 2016 Pr XOLAIR is a registered trademark AstraZeneca Canada Inc
The product monograph is an integral part of New Drug, Supplement to a New Drug, Abbreviated New Drug and Supplement to an Abbreviated New Drug Submissions
17,300 Trans-Canada Highway Kirkland, Quebec H9J 2M5 ® C
2150 St
PROSCAR ® Product Monograph Consumer Information Important Information for Healthcare Professionals – January 2024
Date of Preparation: 8699 8th Avenue February 25, 1997 Montréal, Canada Date of Revision: H1Z 2X4 June 17, 2004 Control # : 092228, 092229 PRODUCT